Salwa Agha Mohammad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Salwa Agha Mohammad has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Ahmed Hafez Mousa
Neurosciences, Dubai Health, Dubai, United Arab Emirates
3 shared publications Asim Muhammad Alshanberi
Batterjee Med Coll, Med Program, Jeddah 21442, Saudi Arabia
1 shared publicationAsim Muhammed Alshanberi
Department of Community Medicine and Pilgrims Health Care, Umm Alqura University, Makkah, 24382, Saudi Arabia
1 shared publicationHanin Radwan
Batterjee Med Coll, Med Program, Jeddah 21442, Saudi Arabia
1 shared publicationHassan Mohammed Rezk
Department of Human Anatomy and Embryology, Mansoura University, Mansoura, Egypt
1 shared publication- Khadijah Hassan Muzaffar
Department of Medicine and Surgery, Batterjee Medical College, Jeddah, Makkah, 21442, Saudi Arabia
1 shared publication
Latest Publications
- Open Access
- 1 September 2022
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 81, 104410
Choice of medicine program: A single-institution study
Introduction: The decision to apply for medical school is the first and one of the most important career choices that a physician will ever make and the motives for choosing a career in medicine seem to remain relatively stable during medical school. Our study aimed to investigate what motivated the students, their satisfaction with the PBL curriculum and their plans following graduation. Methods: A cross-sectional descriptive study was carried out from Jan to March 2021 at Batterjee medical college, Jeddah. The data was collected on a questionnaire from undergraduate students of first year till the internship year. Results: Among the 112 students who completed the questionnaire, 85 (75.9%) chose studying medicine to be their own choice, with service to humanity 56 (50%) being the main reason, followed by monetary 20 (18.8%) reasons. Generally 78 (69.6%) of the responders preferred the PBL curriculum over the traditional one. Most of the students 42 (37.5%) planned to undergo the residency program in Saudi Arabia, with general surgery being the specialty preferred by 33 (29.5%) students. Conclusion: The findings in our study suggest that altruism is the most common influencing factor that led students joining a medical college
- 1 September 2022
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 81, 104410
Open AccessChoice of medicine program: A single-institution study
Introduction: The decision to apply for medical school is the first and one of the most important career choices that a physician will ever make and the motives for choosing a career in medicine seem to remain relatively stable during medical school. Our study aimed to investigate what motivated the students, their satisfaction with the PBL curriculum and their plans following graduation. Methods: A cross-sectional descriptive study was carried out from Jan to March 2021 at Batterjee medical college, Jeddah. The data was collected on a questionnaire from undergraduate students of first year till the internship year. Results: Among the 112 students who completed the questionnaire, 85 (75.9%) chose studying medicine to be their own choice, with service to humanity 56 (50%) being the main reason, followed by monetary 20 (18.8%) reasons. Generally 78 (69.6%) of the responders preferred the PBL curriculum over the traditional one. Most of the students 42 (37.5%) planned to undergo the residency program in Saudi Arabia, with general surgery being the specialty preferred by 33 (29.5%) students. Conclusion: The findings in our study suggest that altruism is the most common influencing factor that led students joining a medical college
- Open Access
- 3 June 2022
- Published by Springer Nature in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
- Vol. 58 (1) , 1-8
Potential role of chitosan, PLGA and iron oxide nanoparticles in Parkinson’s disease therapy
Background: Parkinson's disease (PD) is a debilitating disease that alters an individual's functionality. Parkinsonism is a complex symptom consisting of numerous motor and non-motor features, and although several disorders are responsible, PD remains the most important. Several theories have been proposed for the characteristic pathological changes, the most important of which is the loss of dopaminergic neurons associated with a reduced ability to perform voluntary movements. Many drugs have been developed over the years to treat the condition and prevent its progression, but drug delivery is still a challenge due to the blood–brain barrier, which prevents the passage of drugs into the central nervous system. However, with the advances in nanotechnology in the medical field, there is growing hope of overcoming this challenge. Summary: Our review highlights the potential role of three commonly studied nanoparticles in laboratory-induced animal models of PD: chitosan, PLGA, and iron oxide nanoparticles as potential PD therapy in humans.
- 3 June 2022
- Published by Springer Nature in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
- Vol. 58 (1) , 1-8
Open AccessPotential role of chitosan, PLGA and iron oxide nanoparticles in Parkinson’s disease therapy
Background: Parkinson's disease (PD) is a debilitating disease that alters an individual's functionality. Parkinsonism is a complex symptom consisting of numerous motor and non-motor features, and although several disorders are responsible, PD remains the most important. Several theories have been proposed for the characteristic pathological changes, the most important of which is the loss of dopaminergic neurons associated with a reduced ability to perform voluntary movements. Many drugs have been developed over the years to treat the condition and prevent its progression, but drug delivery is still a challenge due to the blood–brain barrier, which prevents the passage of drugs into the central nervous system. However, with the advances in nanotechnology in the medical field, there is growing hope of overcoming this challenge. Summary: Our review highlights the potential role of three commonly studied nanoparticles in laboratory-induced animal models of PD: chitosan, PLGA, and iron oxide nanoparticles as potential PD therapy in humans.
- Open Access
- 25 August 2021
- Published by F1000 Research Ltd in F1000Research
- Vol. 10, 850
Nanoparticles in traumatic spinal cord injury: therapy and diagnosis
Nanotechnology has been previously employed for constructing drug delivery vehicles, biosensors, solar cells, lubricants and as antimicrobial agents. The advancement in synthesis procedure makes it possible to formulate nanoparticles (NPs) with precise control over physico-chemical and optical properties that are desired for specific clinical or biological applications. The surface modification technology has further added impetus to the specific applications of NPs by providing them with desirable characteristics. Hence, nanotechnology is of paramount importance in numerous biomedical and industrial applications due to their biocompatibility and stability even in harsh environments. Traumatic spinal cord injuries (TSCIs) are one of the major traumatic injuries that are commonly associated with severe consequences to the patient that may reach to the point of paralysis. Several processes occurring at a biochemical level which exacerbate the injury may be targeted using nanotechnology. This review discusses possible nanotechnology-based approaches for the diagnosis and therapy of TSCI, which have a bright future in clinical practice.
- 25 August 2021
- Published by F1000 Research Ltd in F1000Research
- Vol. 10, 850
Open AccessNanoparticles in traumatic spinal cord injury: therapy and diagnosis
Nanotechnology has been previously employed for constructing drug delivery vehicles, biosensors, solar cells, lubricants and as antimicrobial agents. The advancement in synthesis procedure makes it possible to formulate nanoparticles (NPs) with precise control over physico-chemical and optical properties that are desired for specific clinical or biological applications. The surface modification technology has further added impetus to the specific applications of NPs by providing them with desirable characteristics. Hence, nanotechnology is of paramount importance in numerous biomedical and industrial applications due to their biocompatibility and stability even in harsh environments. Traumatic spinal cord injuries (TSCIs) are one of the major traumatic injuries that are commonly associated with severe consequences to the patient that may reach to the point of paralysis. Several processes occurring at a biochemical level which exacerbate the injury may be targeted using nanotechnology. This review discusses possible nanotechnology-based approaches for the diagnosis and therapy of TSCI, which have a bright future in clinical practice.